Grupo Vithas, the Healthcare group headed by the Gallardo family and Criteria Caixa bank, has hit trouble in their attempts to buy Valencia based Grupo Hospitales Nisa and its seven healthcare centers throughout Valencia, Madrid and Andalucía provinces. Vithas, based in Madrid and with Catalan backing, has said it intends to complete the takeover in order to widen their network, becoming Spain’s second largest private hospital group.
While Vithas has managed to secure purchasing options from some of Nisa’s major shareholders (totalling around 30% of shares), the company has also met serious resistance from well-organized minority shareholders, who have launched a share-merger process in order to present a united front and “a position of strength.” Together, the resisting shareholders represent over 53% of NIsa’s active shares.
A number of these shareholders have considered Vithas’ move to be a hostile takeover, having rejected their offers and the extended two-year payment plan. As a result, Vithas decided not to press ahead with the initial round of purchases, whose options were to expire in late June.
Full Content: El Confidencial/a>
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
UK Antitrust Regulator Signals Flexibility in Merger Reviews to Boost Economic Growth
Nov 21, 2024 by
CPI
US Supreme Court Declines to Hear Appeal in Google Antitrust Records Dispute
Nov 21, 2024 by
CPI
Matt Gaetz Withdraws from Consideration for US Attorney General Amid Controversy
Nov 21, 2024 by
CPI
Morocco Fines US Pharma Firm Viatris Over Merger Notification Breach
Nov 21, 2024 by
CPI
FCC Chairwoman Rosenworcel Announces Resignation
Nov 21, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Remedies Revisited
Oct 30, 2024 by
CPI
Fixing the Fix: Updating Policy on Merger Remedies
Oct 30, 2024 by
CPI
Methodology Matters: The 2017 FTC Remedies Study
Oct 30, 2024 by
CPI
U.S. v. AT&T: Five Lessons for Vertical Merger Enforcement
Oct 30, 2024 by
CPI
The Search for Antitrust Remedies in Tech Leads Beyond Antitrust
Oct 30, 2024 by
CPI